Temozolomide in Treating Patients With Low-Grade Glioma
Clinical trial NCT00313729 · COMPLETED
Trial details
- NCT number
- NCT00313729
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-05-01
- Primary completion
- 2014-09-25
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.